PTC appoints clinical development head
This article was originally published in Scrip
PTC Therapeutics has named Dr Tuyen Ong senior vice-president and head of clinical development and translational research. He will be responsible for clinical development and operations across all of PTC's therapeutic areas including genetic disorders, oncology and anti-infectives. Prior to joining PTC, Dr Ong was vice-president of global clinical development and operations at Valeant Pharmaceuticals (previously Bausch + Lomb).